证券代码：002615 证券简称：哈尔斯 公告编号：2025-066 浙江哈尔斯真空器皿股份有限公司 关于调整 2020 年限制性股票激励计划回购价格的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 浙江哈尔斯真空器皿股份有限公司（以下简称"哈尔斯"或"公司"）于 2025 年 8 月 19 日召开第六届董事会薪酬与考核委员会第八次会议、于 2025 年 8 月 了《关于调整 2020 年限制性股票激励计划回购价格的议案》。现将有关情况公告 如下： 一、2020 年限制性股票激励计划简述 于〈2020年限制性股票激励计划（草案）〉及其摘要的议案》 《关于〈2020年限制 性股票激励计划实施考核管理办法〉的议案》《关于提请股东大会授权董事会办 理股权激励相关事宜的议案》，公司独立董事发表了同意的独立意见。 于〈2020年限制性股票激励计划（草案）〉及其摘要的议案》 《关于〈2020年限制 性股票激励计划实施考核管理办法〉的议案》《关于核实〈2020年限制性股票激 励计划首次授予部分激励对象名单〉的议案》。公司监事会就公司2020年限制性 股票激励计划首次授 ...

证券代码：300502 证券简称：新易盛 公告编号：2025-044 成都新易盛通信技术股份有限公司 关于 2024 年限制性股票激励计划预留授予第一期 归属条件成就的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 的 0.0259%。 通的公告，敬请投资者关注。 成都新易盛通信技术股份有限公司（以下简称"公司"）于 2025 年 8 月 25 日召开第五届董事会第九次会议、第五届监事会第九次会议，审议通过了《关于 归属条件的激励对象共 41 人，可申请归属的第二类限制性股票数量 25.746 万股， 占公司股本总额的 0.0259%，归属价格为 16.168 元/股，现对有关事项说明如下： 一、股权激励计划简述及已履行的相关审批程序 （一）限制性股票激励计划简述 公司于 2024 年 1 月 3 日召开第四届董事会第十六次会议和第四届监事会第 十六次会议，并于 2024 年 1 月 19 日公司召开 2024 年第一次临时股东大会，审 议通过了《2024 年限制性股票激励计划（草案）》（以下简称"《激励计划（草 案）》"、"本激励计划" ...

北京康达（成都）律师事务所 关于四川路桥建设集团股份有限公司 2021 年限制性股票 四川省成都市东御街 18 号百扬大厦 1 栋 11 楼邮编：610000 法律意见书 电话/TEL:（028）87747485 传真/FAX： （028）86512848 网址/WEBSITE：www.kangdacdlawyers.com 激励计划之部分限制性股票回购注销相关事项的 法律意见书 康达（成都）法意字[2025]第 0507 号 二〇二五年八月 北京 BEIJING 上海 SHANGHAI 广州 GUANGZHOU 深圳 SHENZHEN 海口 HAIKOU 西 安 XI'AN 天津 TIANJIN 杭州 HANGZHOU 南京 NANJING 沈阳 SHENYANG 成都 CHENGDU 菏泽 HEZE 苏 州 SUZHOU 武汉 WUHAN 香港 HONGKONG 呼和浩特 HUHEHAOTE 1厦门 XIAMEN 长沙 CHANGSHA 重 庆 CHONGQING 郑州 ZHENGZHOU 合肥 HEFEI 宁波 NINGBO 济南 JINAN 昆明 KUNMING 南昌 NANCHANG 法律意见书 北 ...

Group 1 - The board of directors of Shanghai Sanyou Medical Instrument Co., Ltd. held its third meeting of the fourth session on August 22, 2025, with all nine directors present, and the meeting was deemed legally valid [1][2]. - The board approved the draft of the 2025 Restricted Stock Incentive Plan, which aims to align the interests of core employees with the long-term development of the company, thereby maximizing value for both the company and its shareholders [2][3]. - The board also approved the implementation assessment management measures for the 2025 Restricted Stock Incentive Plan, ensuring compliance with relevant laws and facilitating the plan's smooth execution [3][4]. Group 2 - The board proposed to seek authorization from the shareholders' meeting to handle matters related to the 2025 Restricted Stock Incentive Plan, including determining eligibility for participants and making necessary adjustments in case of corporate actions [4][5]. - The board's proposal to convene the fourth temporary shareholders' meeting of 2025 was also approved, with details published on the Shanghai Stock Exchange website [5][6].

Group 1 - The board of directors of Beijing Huaru Technology Co., Ltd. held its 11th meeting of the 5th session, with all 6 directors present, and the meeting was deemed legally valid [1] - The board approved the 2025 semi-annual report, confirming that it accurately reflects the company's operational status for the first half of 2025 without any false statements or omissions [1][2] - The board also confirmed that the use of funds raised from the initial public offering complied with relevant regulations, and the report on the use of these funds was approved [2] Group 2 - The company proposed a 2025 restricted stock incentive plan draft to attract and retain talent, aligning the interests of shareholders, the company, and core team members [3][4] - The board authorized to determine the grant date and make necessary adjustments to the number of restricted stocks in case of capital changes [4][5] - The board's proposal for the 2025 employee stock ownership plan draft aims to enhance employee engagement and ensure long-term development [5][8] Group 3 - The board requested authorization from the shareholders' meeting to manage the 2025 employee stock ownership plan, including establishing, modifying, and terminating the plan [8][9] - The board's authorization will remain effective until the completion of the employee stock ownership plan [9] - A second extraordinary shareholders' meeting is scheduled for September 10, 2025, to discuss these proposals [9]

Meeting Information - The company will hold its second extraordinary general meeting of shareholders for 2025 on September 10, 2025, at 14:30, combining on-site voting and online voting [1][2] - The meeting is convened by the fifth board of directors and complies with relevant laws and regulations [1][2] - The registration date for shareholders is September 3, 2025 [2] Voting Procedures - Shareholders can choose between on-site voting and online voting, with the online voting period from 9:15 to 15:00 on the meeting day [2][5] - The meeting will include proposals that require a two-thirds majority approval from attending shareholders [4] Agenda Items - The meeting will discuss several proposals, including the 2025 Restricted Stock Incentive Plan and the 2025 Employee Stock Ownership Plan [3][4] - All proposals are categorized as special resolutions, requiring specific voting procedures for related shareholders [4] Registration and Attendance - Registration for the meeting will take place on September 9, 2025, from 9:00 to 17:00 [4] - Shareholders must provide necessary documentation for registration, including identification and proof of shareholding [4][5] Contact Information - For inquiries, shareholders can contact the company via phone or email, with specific details provided for communication [5]

Core Viewpoint - The legal opinion letter from Shanghai Jintiancheng Law Firm confirms that Hangzhou Tiandi Digital Technology Co., Ltd. has fulfilled the necessary procedures for the release of restrictions on its stock and the adjustment of the repurchase price in accordance with relevant laws and regulations [1][10]. Group 1: Authorization and Procedures - The company has obtained shareholder approval for the 2023 Restricted Stock Incentive Plan, allowing the board to adjust the repurchase price and decide on the release of restrictions on stock [5]. - The board has been authorized to handle all matters necessary for the release of restrictions and the adjustment of the repurchase price [5]. - The company has completed the required procedures for the release of restrictions and the adjustment of the repurchase price [6]. Group 2: Release of Restrictions Conditions - The second release period for the restricted stock is set to occur from September 18, 2025, to September 17, 2026, allowing for a 30% release of the total granted stock [6]. - The conditions for the release of restrictions include meeting specific financial performance metrics, such as a revenue growth rate of at least 15% in 2024 compared to 2023 [8]. Group 3: Adjustment of Repurchase Price - The repurchase price for the restricted stock has been adjusted from 7.14 CNY per share to 6.64 CNY per share due to the implementation of the 2024 annual profit distribution plan [9]. - The adjustment method for the repurchase price is based on the company's capital changes, ensuring that the adjusted price remains above 1 CNY [9]. Group 4: Conclusion - The legal opinion concludes that the company has met all necessary legal requirements and that the conditions for the release of restrictions have been satisfied, barring any changes in the status of the incentive recipients [10].

证券简称：三友医疗 证券代码：688085 独立财务顾问报告 目 录 一、释义 ·························································································· 3 二、声明 ·························································································· 4 三、基本假设 ···················································································· 5 四、独立财务顾问意见 ········································································ 6 （一） 对公司实行 2025 年限制性股票激励计划条件的核查意见 ················6 （二） 对 2025 年限制性股票激励计划内容及可行性的核查意见 ················7 ...

Core Viewpoint - The company is proposing a restricted stock incentive plan for 2025, aimed at attracting and retaining talent while aligning the interests of shareholders, the company, and core team members [2][9][22]. Group 1: Incentive Plan Overview - The incentive plan involves granting up to 1.05 million restricted stocks, accounting for approximately 0.67% of the company's total share capital of 155.865 million shares [2][13]. - The grant price for the restricted stocks is set at 13.57 yuan per share [2][19]. - The plan is designed to motivate four senior management and key employees, excluding independent directors and major shareholders [4][12]. Group 2: Conditions and Adjustments - The plan stipulates that the grant and vesting of stocks will be adjusted in case of corporate actions like stock dividends or capital increases [3][13]. - The vesting period for the restricted stocks is a maximum of 48 months, with specific performance targets set for each year [6][19]. - The performance targets include achieving a net profit of no less than 1 million yuan for the year 2025 [20][22]. Group 3: Governance and Compliance - The company's board of directors is responsible for implementing the plan, with oversight from the remuneration and assessment committee [9][10]. - The plan requires approval from the shareholders' meeting before implementation [10][12]. - The company commits not to provide financial assistance to the incentive recipients for acquiring the restricted stocks [4][12]. Group 4: Accounting and Financial Impact - The company will account for the stock incentive costs according to relevant accounting standards, estimating the impact on net profit during the vesting period [27][28]. - The estimated total expense for the stock incentive plan will be amortized over the vesting period, affecting the company's financial statements [27][28]. Group 5: Termination and Changes - The plan may be terminated if the company faces adverse conditions such as negative audit opinions or failure to distribute profits as promised [29][30]. - Changes in the legal framework regarding stock incentives will be adhered to, ensuring compliance with updated regulations [12][29].

证券代码：300743 证券简称：天地数码 公告编号：2025-066 杭州天地数码科技股份有限公司 关于公司 2023 年限制性股票激励计划首次授予部分第二个 解除限售期条件成就的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 分第二个解除限售期条件已经成就，本次符合解除限售的激励对象共 32 名，可 解除限售的限制性股票数量为 226,584 股，占公司目前总股本 151,240,499 股的 司届时将发布相关提示性公告，敬请广大投资者关注。 杭州天地数码科技股份有限公司（以下简称"公司"）于 2025 年 8 月 22 日召开第四届董事会第二十三次会议和第四届监事会第二十三次会议，审议通过 了《关于公司 2023 年限制性股票激励计划首次授予部分第二个解除限售期条件 成就的议案》，同意为 32 名符合解除限售条件的激励对象办理 226,584 股限制 性股票解除限售相关事宜。现将具体内容公告如下： 一、本次激励计划已履行的相关审批程序 《关于公司<2023 年限制性股票激励计划（草案）>及其摘要的议案》《关于公 司<2023 年限制性股 ...